Clinical Trial Update: Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bendamustine/rituxan induction chemotherapy followed by Revlimid maintenance in relapsed/refractory chronic lymphocytic leukemia and sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Revlimid (lenalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-07-13